The creation of a “negotiating class” to settle thousands of the nation’s opioid lawsuits may have far reaching implications for tort defendants and their insurers. Adam H. Fleischer, Chair of BatesCarey’s Opioid Coverage Task Force, examines these issues in his latest Law360 Expert Analysis here.